Suppr超能文献

估算肾小球滤过率以调整重症患者万古霉素剂量:慢性肾脏病流行病学合作组织方程的优势?

Estimation of glomerular filtration rate to adjust vancomycin dosage in critically ill patients: superiority of the Chronic Kidney Disease Epidemiology Collaboration equation?

作者信息

Conil J M, Georges B, Breden A, Ruiz S, Cougot P, Fourcade O, Saivin S

机构信息

Anaesthesia Resusciation Department, Rangueil Hospital, Toulouse, France.

出版信息

Anaesth Intensive Care. 2014 Mar;42(2):178-84. doi: 10.1177/0310057X1404200203.

Abstract

The purpose of this study was to determine the best estimate of glomerular filtration rate (GFR) to adjust vancomycin (VAN) dosage in critically ill patients. Seventy-eight adult intensive care unit patients received a 15 mg/kg loading dose of VAN plus a 30 mg/kg/day continuous infusion. Steady-state concentration was measured 48 hours later and the dose was adjusted to obtain a target concentration ranging from 20 to 25 mg/l. GFR was estimated by measured creatinine clearance (CLCR), Cockcroft, Modification of Diet in Renal Disease and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations. The required dose providing the target concentration was 36±17 mg/kg/day. The first dosage had to be increased in 51% of all patients and in 84% of trauma patients (highest GFR), but had to be decreased in 17% of patients. The closest relationship between clearances of vancomycin was observed with CKD-EPI to GFR. The correlation between clearances of vancomycin and measured CLCR was significant but was rather poor with Cockcroft and Modification of Diet in Renal Disease equation. On the Bland and Altman plots, measured CLCR provided a lower bias but a larger confidence interval and a weaker precision than CKD-EPI. For VAN dose adjustments in intensive care unit patients, Cockcroft formula and Modification of Diet in Renal Disease should be used with caution. In clinical practice, the physician does not have at their disposal the patient's measured CLCR when prescribing. The CKD-EPI appears to be the best predictor of clearances of vancomycin for calculation of a therapeutic VAN regimen.

摘要

本研究的目的是确定在危重症患者中调整万古霉素(VAN)剂量时肾小球滤过率(GFR)的最佳估计值。78例成年重症监护病房患者接受了15mg/kg的VAN负荷剂量加30mg/kg/天的持续输注。48小时后测量稳态浓度,并调整剂量以获得20至25mg/l的目标浓度。通过测量的肌酐清除率(CLCR)、Cockcroft公式、肾脏病饮食改良公式和慢性肾脏病流行病学协作组(CKD-EPI)公式估算GFR。达到目标浓度所需的剂量为36±17mg/kg/天。所有患者中有51%以及创伤患者(GFR最高)中有84%需要增加首次剂量,但17%的患者需要减少剂量。观察到万古霉素清除率与CKD-EPI估算的GFR之间的关系最为密切。万古霉素清除率与测量的CLCR之间的相关性显著,但与Cockcroft公式和肾脏病饮食改良公式的相关性较差。在Bland和Altman图上,测量的CLCR偏差较小,但置信区间较大且精度低于CKD-EPI。对于重症监护病房患者的VAN剂量调整,应谨慎使用Cockcroft公式和肾脏病饮食改良公式。在临床实践中,医生在开处方时无法获得患者测量的CLCR。CKD-EPI似乎是计算治疗性VAN方案时万古霉素清除率的最佳预测指标。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验